Cargando…

‘SMASH’ recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models

Animal models for inflammatory arthritides such as rheumatoid arthritis (RA) and psoriatic arthritis are widely accepted and frequently used to identify pathological mechanisms and validate novel therapeutic strategies. Unfortunately, many publications reporting on these animal studies lack detailed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayer, Silvia, Vervoordeldonk, Margriet J, Denis, Maria C, Armaka, Marietta, Hoffmann, Markus, Bäcklund, Johan, Nandakumar, Kutty Selva, Niederreiter, Birgit, Geka, Christina, Fischer, Anita, Woodworth, Nina, Blüml, Stephan, Kollias, George, Holmdahl, Rikard, Apparailly, Florence, Koenders, Marije I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Recommendation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142455/ https://www.ncbi.nlm.nih.gov/pubmed/33602797 http://dx.doi.org/10.1136/annrheumdis-2020-219247

Ejemplares similares

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
por: Nandakumar, Kutty Selva, et al.
Publicado: (2004)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR definition of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2021)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development
por: Bäcklund, Alexandra, et al.
Publicado: (2011)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
por: Fisher, Benjamin A, et al.
Publicado: (2017)

Treating rheumatoid arthritis to target: the patient version of the international recommendations
por: de Wit, M P T, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity
por: Carlsen, Stefan, et al.
Publicado: (2006)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2016)

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
por: Nikiphorou, Elena, et al.
Publicado: (2021)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2014)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Recommendations of the Moroccan Society of Rheumatology (SMR) for Diagnostic Management of Spondyloarthritis (SpA) and Psoriatic Arthritis (PsA)
por: Bentaleb, Ibtissam, et al.
Publicado: (2023)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis
por: Boonen, Annelies, et al.
Publicado: (2021)

Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process
por: García-Vicuña, Rosario, et al.
Publicado: (2021)

The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts
por: Armaka, Marietta, et al.
Publicado: (2018)

Human NCF1(90H) Variant Promotes IL-23/IL-17—Dependent Mannan-Induced Psoriasis and Psoriatic Arthritis
por: Li, Yanpeng, et al.
Publicado: (2023)

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Visser, K, et al.
Publicado: (2008)

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Machado, P, et al.
Publicado: (2010)

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
por: Pappas, Dimitrios A, et al.
Publicado: (2021)

Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat
por: Tuncel, Jonatan, et al.
Publicado: (2016)

A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2010)

Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
por: Geng, Hui, et al.
Publicado: (2008)

Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
por: Li, Yanpeng, et al.
Publicado: (2020)

The involvement of Toll‐like receptor 9 in the pathogenesis of erosive autoimmune arthritis
por: Fischer, Anita, et al.
Publicado: (2018)

Genetic dissection of a major haplotype associated with arthritis reveal FcγR2b and FcγR3 to act additively
por: Vaartjes, Daniëlle, et al.
Publicado: (2020)

Diagnostic accuracy of 14‐3‐3 η protein in rheumatoid arthritis: A meta‐analysis
por: Wang, Decai, et al.
Publicado: (2020)

Characterization of chronic relapsing antibody mediated arthritis in mice with a mutation in Ncf1 causing reduced oxidative burst
por: Liang, Peibin, et al.
Publicado: (2022)

Effect of mannose‐binding lectin gene polymorphisms on the risk of rheumatoid arthritis: Evidence from a meta‐analysis
por: Xu, Jinjian, et al.
Publicado: (2021)

Genetic Studies in Experimental Arthritis
por: Holmdahl, Rikard
Publicado: (2000)

Association of MHC and rheumatoid arthritis: Why is rheumatoid arthritis associated with the MHC genetic region? An introduction
por: Holmdahl, Rikard
Publicado: (2000)

Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis
por: Armaka, Marietta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_phcmrbtcpg25580a265iu7kgbn